Manoel Sarno1,2, Gielson A Sacramento3, Ricardo Khouri3, Mateus S do Rosário1, Federico Costa2,3,4, Gracinda Archanjo1, Luciane A Santos3, Nivison Nery3, Nikos Vasilakis5, Albert I Ko3,4, Antonio R P de Almeida1,2. 1. Hospital Geral Roberto Santos, Secretaria Estadual da Saúde da Bahia, Salvador, Bahia, Brazil. 2. Faculdade de Medicina da Bahia and Instituto da Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil. 3. Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Sáude, Salvador, Bahia, Brazil. 4. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America. 5. Department of Pathology and Center of Biodefense and Emerging Infectious Diseases, Institute for Human Infections and Immunity, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Abstract
BACKGROUND: The rapid spread of Zika virus in the Americas and current outbreak of microcephaly in Brazil has raised attention to the possible deleterious effects that the virus may have on fetuses. METHODOLOGY/PRINCIPAL FINDINGS: We report a case of a 20-year-old pregnant woman who was referred to our service after a large Zika virus outbreak in the city of Salvador, Brazil with an ultrasound examination that showed intrauterine growth retardation of the fetus at the 18th gestational week. Ultrasound examinations in the 2nd and 3rd trimesters demonstrated severe microcephaly, hydranencephaly, intracranial calcifications and destructive lesions of posterior fossa, in addition to hydrothorax, ascites and subcutaneous edema. An induced labor was performed at the 32nd gestational week due to fetal demise and delivered a female fetus. ZIKV-specific real-time polymerase chain reaction amplification products were obtained from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid, while extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products. CONCLUSIONS/SIGNIFICANCE: This case report provides evidence that in addition to microcephaly, there may be a link between Zika virus infection and hydrops fetalis and fetal demise. Given the recent spread of the virus, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
BACKGROUND: The rapid spread of Zika virus in the Americas and current outbreak of microcephaly in Brazil has raised attention to the possible deleterious effects that the virus may have on fetuses. METHODOLOGY/PRINCIPAL FINDINGS: We report a case of a 20-year-old pregnant woman who was referred to our service after a large Zika virus outbreak in the city of Salvador, Brazil with an ultrasound examination that showed intrauterine growth retardation of the fetus at the 18th gestational week. Ultrasound examinations in the 2nd and 3rd trimesters demonstrated severe microcephaly, hydranencephaly, intracranial calcifications and destructive lesions of posterior fossa, in addition to hydrothorax, ascites and subcutaneous edema. An induced labor was performed at the 32nd gestational week due to fetal demise and delivered a female fetus. ZIKV-specific real-time polymerase chain reaction amplification products were obtained from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid, while extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products. CONCLUSIONS/SIGNIFICANCE: This case report provides evidence that in addition to microcephaly, there may be a link between Zika virus infection and hydrops fetalis and fetal demise. Given the recent spread of the virus, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
The current outbreak of microcephaly has raised speculations that Zika virus (ZIKV) causes a congenital syndrome. ZIKV, a mosquito-borne flavivirus, was detected in Brazil in early 2015 [1,2] and has rapidly spread throughout the Americas [3]. A large increase in the number of newborns with microcephaly was subsequently identified in Brazil in November 2015. At present, more than 4,500 microcephaly cases have been reported [4]. ZIKV has been detected in few cases, seven in total to date, of fetuses and newborns who died shortly after birth, all of whom had ultrasound abnormalities or pathological lesions which were restricted to the central nervous system [5-7]. Herein, we report a case of a fetus that in addition to hydranencephaly, developed hydrops fetalis and fetal demise in association with congenital ZIKV infection.
Methods
While conducting an outbreak investigation in Salvador, Brazil, we identified a patient who was referred to Hospital Geral Roberto Santos with an abnormal fetal ultrasound examination and followed during outpatient evaluations. After fetal demise and induced labor, tissues aspirates and fragments were collected by needle aspiration and thoraco-abdominal viscerotomy, respectively, since an autopsy could not be performed. RNA was extracted and tested by a ZIKV-specific reverse transcriptase-polymerase transcriptase assay (RT-PCR) [8].
Results
We assumed the care for a 20-year-old woman (gravida 3, para 1) in the 18th week of gestation whose ultrasound examination showed low fetal weight. The patient procured prenatal care during the 4th gestational week in July, 2015 at which time she was found to have a negative serology for HIV, HTLV and hepatitis C viruses and positive IgG and negative IgM ELISA results for toxoplasmosis, rubella virus and cytomegalovirus. She had an uneventful course of pregnancy with a normal ultrasound evaluation at the 14th gestational week. In the 18th week, ultrasound examination found that the fetus had a weight three standard deviations below the mean value for gestational age.On referral, the patient did not report an episode of rash, fever, or body pain or receiving a diagnosis for zika, chikungunya or dengue virus infection during the pregnancy. She denied a family history of an illness suggestive of a Zika virus infection or congenital disorders. Her clinical evaluation was unremarkable. Ultrasound examinations performed at the 26th and 30th gestational weeks showed microcephaly, hydranencephaly with minimal residual cortical parenchyma (Fig 1, Panel A), intracranial calcifications and destructive lesions of posterior fossa (Fig 1, Panel B). The examinations were also significant for the findings of hydrothorax, ascites and subcutaneous edema (Fig 1, Panels C and D).
Fig 1
Axial ultrasound views of the fetus at the 30
Axial ultrasound views of the fetus at the 30An induced labor was performed when ultrasound examination in the 32nd gestational week showed fetal demise and delivered a female fetus with a weight of 930g and signs of microcephaly and arthrogryposis. We obtained ZIKV-specific RT-PCR amplification products from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid. Analysis of extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products. Amplification products mapped within the NS5 gene of ZIKV strains belonging to the Asian lineage, with closest relationship to sequences from French Polynesian and Surinamese strains. The patient gave consent to have her case details published.
Discussion
Attention has focused on the deleterious effects that the ZIKV may have on fetuses due to the rapid global spread of virus and the current outbreak of microcephaly in Brazil. ZIKV has been detected in a small number of cases of fetuses and newborns with microcephaly who have been identified during the outbreak [5-7]. This case report of a fetus provides additional evidence for the link between ZIKV infection and microcephaly. Furthermore, it serves as an alert to clinicians that in addition to central nervous system and ophthalmological manifestations [6,7,9], congenital ZIKV infection may cause hydrops fetalis and fetal demise.Since the majority (73%) of ZIKV infections are asymptomatic [10], it is likely that exposures in pregnant women, such as in the case of our patient, often go unnoticed. We could not document acute infection in the mother and discard the possibility, albeit unlikely, that the severe manifestations, observed in this case, was caused by another process and intrauterine ZIKV infection occurred afterwards. The first indication of an abnormal pregnancy was the ultrasound finding of intrauterine growth retardation in the 18th gestational week. The more plausible explanation is that asymptomatic exposure of the mother, prior to this date and likely in the 1st trimester, caused an intrauterine infection which in turn, resulted in hydranencephaly and hydrops fetalis in the fetus.The finding of an association between ZIKV infection and hydrops fetalis suggests that the virus may cause damage to tissues in addition to the fetal central nervous system. Recent autopsy studies found that histopathologic findings and detection of ZIKV in newborns and fetuses with microcephaly were limited to the brain and in some cases, placenta [6,7], indicating that the virus, unlike common congenital viral infections, exhibits tropism to a limited range of tissues. We detected ZIKV RNA in the central nervous system and amniotic fluid and not in heart, lung, liver or placenta, yet our findings were limited by the sampling procedure and lack of histopathological analysis of tissues. The mechanism by which ZIKV may cause hydrops fetalis therefore remains speculative.We cannot extrapolate from this single case the overall risk for developing hydrops fetalis and fetal demise among pregnant women exposed to the virus. The strain detected in this case of fetal demise appears to be the same as the epidemic strain that has spread across the Americas and Caribbean [6,11]. Given that large numbers of pregnant women in the region have been or will be exposed to this strain, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
Authors: A S Oliveira Melo; G Malinger; R Ximenes; P O Szejnfeld; S Alves Sampaio; A M Bispo de Filippis Journal: Ultrasound Obstet Gynecol Date: 2016-01 Impact factor: 7.299
Authors: Michelle N D Balm; Chun Kiat Lee; Hong Kai Lee; Lily Chiu; Evelyn S C Koay; Julian W Tang Journal: J Med Virol Date: 2012-09 Impact factor: 2.327
Authors: Roosecelis Brasil Martines; Julu Bhatnagar; M Kelly Keating; Luciana Silva-Flannery; Atis Muehlenbachs; Joy Gary; Cynthia Goldsmith; Gillian Hale; Jana Ritter; Dominique Rollin; Wun-Ju Shieh; Kleber G Luz; Ana Maria de Oliveira Ramos; Helaine Pompeia Freire Davi; Wanderson Kleber de Oliveria; Robert Lanciotti; Amy Lambert; Sherif Zaki Journal: MMWR Morb Mortal Wkly Rep Date: 2016-02-19 Impact factor: 17.586
Authors: Mark R Duffy; Tai-Ho Chen; W Thane Hancock; Ann M Powers; Jacob L Kool; Robert S Lanciotti; Moses Pretrick; Maria Marfel; Stacey Holzbauer; Christine Dubray; Laurent Guillaumot; Anne Griggs; Martin Bel; Amy J Lambert; Janeen Laven; Olga Kosoy; Amanda Panella; Brad J Biggerstaff; Marc Fischer; Edward B Hayes Journal: N Engl J Med Date: 2009-06-11 Impact factor: 91.245
Authors: Bruno de Paula Freitas; João Rafael de Oliveira Dias; Juliana Prazeres; Gielson Almeida Sacramento; Albert Icksang Ko; Maurício Maia; Rubens Belfort Journal: JAMA Ophthalmol Date: 2016-05-01 Impact factor: 7.389
Authors: Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco Journal: Chem Rev Date: 2018-04-13 Impact factor: 60.622
Authors: Vanessa van der Linden; Natacha Calheiros de Lima Petribu; Andre Pessoa; Igor Faquini; Alex R Paciorkowski; Hélio van der Linden; Laura Silveira-Moriyama; Marli Tenório Cordeiro; Adriano Nassri Hazin; A James Barkovich; Charles Raybaud; Marilia de Brito Abath; Erlane Ribeiro; Carlos Eduardo Barros Jucá; Maria de Fátima Viana Vasco Aragão; Patrícia Teresa Coelho Travassos; Patrícia Jungmann Journal: JAMA Neurol Date: 2019-02-01 Impact factor: 18.302